IL105028A0 - 1-(2-arylsulphonylamino)-1-oxoethyl)piperidine derivatives,their preparation and their application in therapy - Google Patents

1-(2-arylsulphonylamino)-1-oxoethyl)piperidine derivatives,their preparation and their application in therapy

Info

Publication number
IL105028A0
IL105028A0 IL105028A IL10502893A IL105028A0 IL 105028 A0 IL105028 A0 IL 105028A0 IL 105028 A IL105028 A IL 105028A IL 10502893 A IL10502893 A IL 10502893A IL 105028 A0 IL105028 A0 IL 105028A0
Authority
IL
Israel
Prior art keywords
group
hydrogen atom
alkyl group
alkyl
application
Prior art date
Application number
IL105028A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL105028A0 publication Critical patent/IL105028A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL105028A 1992-03-30 1993-03-11 1-(2-arylsulphonylamino)-1-oxoethyl)piperidine derivatives,their preparation and their application in therapy IL105028A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9203828A FR2689130B1 (fr) 1992-03-30 1992-03-30 Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
IL105028A0 true IL105028A0 (en) 1993-07-08

Family

ID=9428242

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105028A IL105028A0 (en) 1992-03-30 1993-03-11 1-(2-arylsulphonylamino)-1-oxoethyl)piperidine derivatives,their preparation and their application in therapy

Country Status (21)

Country Link
US (1) US5453430A (de)
EP (2) EP0565396B1 (de)
JP (2) JP2550276B2 (de)
KR (1) KR930019664A (de)
CN (1) CN1076928A (de)
AT (1) ATE161839T1 (de)
AU (1) AU655876B2 (de)
CA (1) CA2092867A1 (de)
CZ (1) CZ52893A3 (de)
DE (1) DE69316068T2 (de)
FI (1) FI931413A (de)
FR (1) FR2689130B1 (de)
HU (1) HUT64758A (de)
IL (1) IL105028A0 (de)
MX (1) MX9301783A (de)
NO (2) NO302572B1 (de)
NZ (1) NZ247277A (de)
PL (1) PL298299A1 (de)
SK (1) SK26393A3 (de)
TW (1) TW234717B (de)
ZA (1) ZA932228B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689130B1 (fr) 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
CA2122397A1 (en) * 1993-05-03 1994-11-04 Spencer D. Kimball Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors
FR2710061B1 (fr) * 1993-09-14 1995-12-29 Synthelabo Acides et chlorures d'acides 1,2,3, 4-tétrahydroquinoléine-8-sulfoniques, et leur utilisation comme intermédiaires de synthèse.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2718444B1 (fr) * 1994-04-12 1996-05-10 Synthelabo Dérivés de (3-méthyl-1, 2, 3, 4-tétrahydroquinoléin-8-yl)sulfonyle, leur préparation et leur application en thérapeutique.
FR2718439B3 (fr) * 1994-04-12 1996-02-09 Synthelabo Dérivés de l'acide pipécolique, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2718443B1 (fr) * 1994-04-12 1996-05-10 Synthelabo Dérivés de 1-[2-[[(3-méthyl-1, 2, 3, 4-tétrahydroquinoléin-8-yl)sulfonyl] amino]-1-oxo-5-(1H-imidazol-4-yl)pentyl]pipéridine, leur préparation et leur application en thérapeutique.
FR2718442B1 (fr) * 1994-04-12 1996-05-10 Synthelabo Dérivés de 5-(1H-imidazol-4-yl)-1-oxopentylpipéridine, leur préparation et leur application en thérapeutique.
DE4424828A1 (de) * 1994-07-14 1996-01-18 Thomae Gmbh Dr K Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel
FR2727413B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Derives de 5-(1h-imidazol-4-yl)-1-oxo-2-(phenylsulfonamino)- pentylpiperidine, leur preparation et leur application en therapeutique
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
GB9505538D0 (en) * 1995-03-18 1995-05-03 Ciba Geigy Ag New compounds
US5811402A (en) * 1996-03-22 1998-09-22 Eli Lilly And Company Antithrombotic diamides
IL125918A0 (en) * 1996-04-22 1999-04-11 Synthelabo Propargylgycine derivatives preparation and utilisation thereof as synthesis intermediates
FR2747677B1 (fr) * 1996-04-22 1998-06-05 Synthelabo Derives de propargylglycine, leur preparation et leur utilisation comme intermediaires de synthese
FR2747676B1 (fr) * 1996-04-22 1998-06-05 Synthelabo Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
US5773089A (en) * 1996-12-18 1998-06-30 E. I. Du Pont De Nemours And Company Process for treating aramid surfaces to be plated
FR2765220B1 (fr) * 1997-06-25 1999-07-30 Synthelabo Derives de 1-oxo-2-(phenylsulfonyl)aminopentyle, leur preparation et leur application en therapeutique
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique
WO2006123020A1 (en) * 2005-05-18 2006-11-23 Juvantia Pharma Ltd Oy Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
AU2009331298B2 (en) * 2008-12-22 2015-04-30 Pola Chemical Industries Inc. Melanin production inhibitor
CN101794567B (zh) * 2010-02-10 2014-01-01 中兴通讯股份有限公司 图片加载的方法及终端
CN104098647B (zh) * 2014-06-24 2017-12-08 安徽省逸欣铭医药科技有限公司 阿加曲班类似物及其制备方法和医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
EP0008596A1 (de) * 1978-09-04 1980-03-19 DEVINTER Europe S.A. Société anonyme dite: Verfahren zur Herstellung von 4-Hydroxymethyl-imidazolderivaten aus übereinstimmenden 4-Imidazolkarbonsäureestern
SE8203887D0 (sv) * 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
DE3771376D1 (de) 1986-03-17 1991-08-22 Glaxo Group Ltd Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CA2043741C (en) * 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
FR2689130B1 (fr) 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
PL298299A1 (en) 1993-10-18
SK26393A3 (en) 1993-12-08
JPH0798807B2 (ja) 1995-10-25
FI931413A (fi) 1993-10-01
AU655876B2 (en) 1995-01-12
NO302572B1 (no) 1998-03-23
AU3556093A (en) 1993-10-07
EP0565396A1 (de) 1993-10-13
EP0565396B1 (de) 1998-01-07
DE69316068T2 (de) 1998-08-13
JPH06199807A (ja) 1994-07-19
NO975664D0 (no) 1997-12-05
ATE161839T1 (de) 1998-01-15
NO931166L (no) 1993-10-01
FR2689130A1 (fr) 1993-10-01
NO975664L (no) 1993-10-01
NZ247277A (en) 1995-07-26
EP0579277A1 (de) 1994-01-19
KR930019664A (ko) 1993-10-18
HUT64758A (en) 1994-02-28
FR2689130B1 (fr) 1994-05-27
US5453430A (en) 1995-09-26
NO931166D0 (no) 1993-03-29
TW234717B (en) 1994-11-21
FI931413A0 (fi) 1993-03-29
CA2092867A1 (fr) 1993-10-01
JPH06157514A (ja) 1994-06-03
CZ52893A3 (en) 1994-02-16
DE69316068D1 (de) 1998-02-12
MX9301783A (es) 1994-02-28
HU9300915D0 (en) 1993-06-28
JP2550276B2 (ja) 1996-11-06
ZA932228B (en) 1993-10-28
CN1076928A (zh) 1993-10-06

Similar Documents

Publication Publication Date Title
IL105028A0 (en) 1-(2-arylsulphonylamino)-1-oxoethyl)piperidine derivatives,their preparation and their application in therapy
AU2044697A (en) Phenylalkylcarboxylic acid derivatives
IE43847L (en) N-substituted phenylpiperidine derivatives.
NZ242154A (en) N-nitrooxyalkyl-2-oxothiazolidine and -oxazoline carboxamide derivatives; their preparation and pharmaceutical compositions
ES8801922A1 (es) Procedimiento para la fabricacion de un ester acido 1 beta-(2-(2-amino-4-tiazolil)alquenoilamino)-3-cefem-4-carboxilico.
AU7624494A (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
DE68927286T2 (de) Pyrrolidin-Derivate
EP0393534A3 (de) Pharmazeutisch wirksame Pteridinderivate
AU4441593A (en) Tetrahydronaphthalene derivatives, their preparation and their application in therapy